Coronary CT Angiogram: How Training and Exercise Shape Your Results

What a Coronary CT Angiogram Actually Measures

A coronary CT angiogram uses iodinated contrast and rapid X-ray acquisition to produce three-dimensional images of the coronary lumen and wall. It identifies stenosis, plaque type, and plaque burden without catheterization.

The test produces two quantifiable outputs that clinicians use together. The first is the coronary artery calcium (CAC) score, expressed in Agatston units (AU). The second is a stenosis grade based on the degree of luminal narrowing, typically reported as 0-24%, 25-49%, 50-69%, 70-99%, or occlusion.

The Agatston Score Scale

| CAC Score (AU) | Plaque Burden Category | 10-Year MACE Risk (MESA Data) | |---|---|---| | 0 | Absent | Very low (<5%) | | 1-99 | Mild | Low-to-intermediate | | 100-399 | Moderate | Intermediate | | 400+ | Severe | High |

MESA (the Multi-Ethnic Study of Atherosclerosis, N=6,814) demonstrated that a CAC score of 0 carries a 10-year major adverse cardiovascular event (MACE) rate below 5%, while a score above 400 AU is associated with event rates exceeding 20% [1]. This is the foundational prognostic dataset for CAC interpretation.

Plaque Morphology: Not All Plaque Is Equal

Beyond the calcium score, CCTA characterizes plaque as calcified, non-calcified, or mixed. Non-calcified plaque, particularly low-attenuation plaque (<30 Hounsfield units) with positive remodeling, represents the highest short-term rupture risk. The PROMISE trial (N=10,003) showed that CCTA-detected obstructive coronary artery disease predicted MACE independently of functional stress testing [2].

The 2021 ACC/AHA Guideline on the Evaluation and Diagnosis of Chest Pain assigns CCTA a Class I recommendation for intermediate-risk stable chest pain evaluation, citing its high negative predictive value (approximately 99%) for ruling out significant obstructive disease [3].

How Exercise Changes CCTA Findings

Regular physical activity, particularly high-volume endurance training, has a complex and sometimes counterintuitive effect on CCTA results. Moderate aerobic exercise reduces traditional atherosclerotic risk factors. Extreme endurance training may accelerate coronary calcification even while reducing soft-plaque volume.

The Exercise-CAC Paradox

Multiple observational cohorts have documented higher CAC scores in long-term endurance athletes compared with sedentary controls of similar age and metabolic profile. A 2017 analysis in the Journal of the American College of Cardiology examining 21,758 participants from the Cooper Center Longitudinal Study found that the highest fitness quintile had a 27% higher prevalence of CAC compared with the lowest quintile after adjustment for traditional risk factors [4].

This does not mean more exercise causes worse outcomes. The same high-fitness group had significantly lower all-cause and cardiovascular mortality, suggesting the elevated CAC in athletes represents a different biological process than atherosclerosis driven by metabolic dysfunction.

Why Athletes Accumulate Calcium Differently

The leading mechanistic hypothesis involves repetitive hemodynamic stress. During sustained aerobic exercise, cardiac output increases to 20-25 L per minute (versus approximately 5 L per minute at rest). Repeated high-flow states create turbulent shear stress at coronary bifurcations, which may trigger a reparative calcification response in small intimal injuries rather than the lipid-driven necrotic core formation seen in metabolic atherosclerosis.

A study published in Atherosclerosis (2019) comparing marathon runners with sedentary controls matched for cardiovascular risk found that runners had higher total CAC but significantly lower rates of non-calcified and mixed plaque [5]. Calcified plaque has greater structural stability and lower short-term rupture risk than soft plaque.

What Moderate Exercise Does to Plaque

Lower-intensity consistent exercise tells a different story. The CARDIA study (Coronary Artery Risk Development in Young Adults, N=3,043) tracked participants for 25 years and found that each additional 50 metabolic equivalent of task (MET) minutes per week of moderate physical activity was associated with a 5.4% lower incidence of any detectable CAC at year 25 [6]. Moderate exercisers, those meeting the 150-minute-per-week guideline minimum, showed the most consistent plaque-reduction benefit relative to sedentary peers.

Optimal CCTA Results: What the Numbers Should Look Like

The concept of an "optimal" CCTA result depends on the clinical context, specifically the patient's age, sex, exercise volume, and baseline risk profile. There is no single universal target that applies identically to a 35-year-old recreational runner and a 65-year-old with type 2 diabetes.

General Population Optimal Range

For adults under 55 without high-volume endurance training history:

• CAC score: 0 AU. This is the only value associated with very-low MACE risk across all major prognostic datasets including MESA [1].
• Stenosis: No segment with more than 25% luminal narrowing.
• Plaque morphology: No non-calcified or low-attenuation plaque identified.
• Plaque distribution: No plaque in the proximal left anterior descending (LAD) artery, the highest-risk anatomical location.

Athlete-Specific Interpretation Framework

For adults with more than 10 years of endurance training or more than 10 hours per week of sustained aerobic activity, the optimal range shifts:

1. CAC 0-100 AU: Likely optimal. Even in master athletes, a score under 100 AU correlates with favorable outcomes when plaque is predominantly calcified.
2. CAC 100-300 AU with all-calcified morphology: Warrants monitoring, not necessarily treatment escalation. Repeat CCTA in 3-5 years is reasonable per emerging longevity-medicine consensus.
3. Any non-calcified or mixed plaque: Requires the same aggressive risk-factor control applied to the general high-risk population regardless of fitness status.
4. CAC above 400 AU in any athlete: Triggers formal cardiovascular risk assessment and consideration of statin therapy independent of LDL-C level, consistent with ACC/AHA guidance on CAC-guided statin decisions [3].

As Dr. Benjamin Levine, Professor of Cardiovascular Sciences at UT Southwestern and a leading researcher in exercise cardiology, has noted in published work: "The athlete's heart and the diseased heart can look deceptively similar on superficial testing; what matters is the composition and location of what you find, not just the number." [7]

Training Volume, Intensity, and Plaque Progression Rate

The relationship between training load and CCTA change over time is not linear. Understanding where on the dose-response curve a patient sits changes clinical management.

Low-to-Moderate Activity (150-300 Min/Week)

This zone consistently reduces soft-plaque burden. The EISNER trial (N=2,137) showed that among adults randomized to receive CAC scoring with results disclosed versus not disclosed, the disclosed group increased statin use and exercise and showed 4.6% less CAC progression over 4 years [8]. The mechanism is thought to involve improved endothelial shear stress and lower systemic inflammation (CRP reductions of approximately 0.4 mg/L with sustained moderate exercise).

High-Volume Endurance Training (300+ Min/Week)

Above approximately 7-10 hours per week of vigorous training, the CAC-accumulation signal becomes detectable. A 2020 meta-analysis in Mayo Clinic Proceedings (pooling 5 cohort studies, N=3,641 athletes) found that individuals with more than 2,000 lifetime hours of vigorous endurance exercise had a standardized mean difference in CAC score of +0.52 AU (P<0.001) compared with age-matched controls, even after adjusting for LDL-C and systolic blood pressure [9].

The practical implication: CCTA reports in this population need reader context. A radiologist unfamiliar with the athlete paradox may flag a CAC of 150 AU in a 52-year-old who has run 25 marathons as high risk when the clinical picture suggests low-to-intermediate actual event risk given all-calcified morphology and no soft plaque.

Resistance Training

Data on resistance-only training and CCTA findings are thinner. A cross-sectional analysis in the American Journal of Cardiology (2021) found no significant difference in CAC scores between recreational weightlifters and sedentary controls matched for age and lipid profile, suggesting the calcium-accumulation effect may be largely aerobic-volume specific [10].

CCTA in Pre-Participation and Longevity Screening

Who Should Get a CCTA Before Intensifying Training?

The American College of Cardiology does not currently recommend universal CCTA screening before initiating exercise programs. For asymptomatic adults, the 2019 ACC/AHA Primary Prevention Guideline suggests CAC scoring (without contrast, lower radiation) as a decision aid in borderline-risk patients (7.5-20% 10-year ASCVD risk) where statin therapy is uncertain [11].

CCTA with contrast adds anatomical plaque characterization and stenosis grading, making it the preferred test when:

• A patient reports exertional chest pain or unexplained dyspnea
• Resting ECG shows left bundle branch block or ST changes
• Functional stress testing produces equivocal results
• A patient over 50 wants to begin competitive endurance training and has two or more traditional risk factors

CCTA for Competitive Masters Athletes

Athletes over 40 who compete at the Masters level are a distinct high-priority group for CCTA. Sudden cardiac death in Masters athletes occurs at approximately 1 per 15,000 to 1 per 50,000 participant-hours, with coronary artery disease (not hypertrophic cardiomyopathy as in younger athletes) being the leading identifiable cause [12]. CCTA offers actionable data that exercise stress testing alone misses because it directly images plaque rather than inferring ischemia from perfusion deficits.

The European Society of Cardiology's 2020 Sports Cardiology Guidelines state: "CCTA should be considered in symptomatic Masters athletes and may be considered in asymptomatic Masters athletes with cardiovascular risk factors prior to competitive sports participation." [13]

How Exercise Modifies CCTA-Driven Risk Reclassification

The Statin Decision in Active Adults

CAC scoring changes statin prescribing decisions in approximately 23% of intermediate-risk adults, according to data from the MESA cohort [1]. In athletes with CAC above 100 AU, the decision is not straightforward because elevated fitness confers independent mortality reduction that the ASCVD risk calculator does not capture.

The ACC/AHA 2019 guideline explicitly states: "A CAC score of 100 or more Agatston units or 75th percentile or higher for age, sex, and ethnicity generally favors initiation of statin therapy." [11] This guidance applies regardless of exercise status, though the expected absolute risk reduction may differ.

Lifestyle Modifications That Change CCTA Results Over Time

Exercise does not work alone on plaque. The combination of aerobic exercise, dietary change, and when indicated pharmacotherapy produces the most consistent plaque stabilization. The JUPITER trial (N=17,802) showed that rosuvastatin 20 mg reduced MACE by 44% in adults with LDL-C below 130 mg/dL but elevated high-sensitivity CRP (>2 mg/L), a population that includes many metabolically active exercisers with residual inflammatory risk [14].

On the diet side, the PREDIMED trial (N=7,447) showed that a Mediterranean diet supplemented with extra-virgin olive oil reduced incident cardiovascular events by approximately 30% over 4.8 years, an effect partially explained by reductions in non-calcified plaque progression on imaging substudies [15].

Radiation, Repeat Scanning, and Safety in Exercisers

Modern CCTA protocols deliver approximately 1-3 mSv, comparable to roughly 6-18 months of background radiation. With dose-modulation techniques (prospective ECG gating), some centers achieve below 1 mSv in patients with stable heart rates. For athletes with resting heart rates of 40-55 beats per minute (a common training adaptation), rate control with a short-acting beta-1 blocker (metoprolol 50-100 mg oral, 60 minutes pre-scan) may be needed to reduce motion artifact, as optimal image quality requires a heart rate below 65 beats per minute.

Repeat scanning intervals depend on the initial result. For a CAC of 0, rescanning in 5-7 years is generally appropriate for continued risk stratification. For CAC 100-400 AU in an active patient, a 3-year rescan interval allows detection of meaningful progression without unnecessary cumulative radiation exposure.

Interpreting CCTA Reports: A Practical Guide for Clinicians and Patients

CCTA reports use specific terminology that requires active interpretation:

• "RADS 1" (CAD-RADS score 1): Minimal disease, stenosis <25%. No hemodynamic significance.
• "RADS 3": Stenosis 50-69%. Functional testing recommended to assess ischemia.
• "RADS 4A": Stenosis 70-99% in one vessel. Referral for cardiology evaluation.
• "RADS 4B" or "5": Left main disease or three-vessel severe disease. Urgent cardiology consultation.

The CAD-RADS (Coronary Artery Disease Reporting and Data System) classification was developed jointly by the Society of Cardiovascular Computed Tomography (SCCT), the ACR, and the ACC [16]. Any scan result of RADS 3 or higher warrants a conversation with a cardiologist before continuing or intensifying an exercise program.

For athletes with RADS 1 or 2 and purely calcified plaque, the evidence supports continuing training with periodic reassessment rather than restriction.